These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9891476)

  • 1. Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor.
    Ikeda T; Murakami K; Hayakawa Y; Fujii H; Ohkoshi M; Saiki I
    Anticancer Res; 1998; 18(6A):4259-65. PubMed ID: 9891476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of tumour--host coexistence In vitro in the presence of serine protease inhibitors.
    Engi H; Gyémánt N; Ohkoshi M; Amaral L; Molnár J
    In Vivo; 2009; 23(5):711-5. PubMed ID: 19779105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan).
    Ohkoshi M; Sasaki Y
    In Vivo; 2005; 19(1):133-6. PubMed ID: 15796165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
    Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent growth-suppressive activity of a serine protease inhibitor, ONO-3403, toward malignant human neuroblastoma cell lines.
    Hiwasa T; Kondo K; Nakagawara A; Ohkoshi M
    Cancer Lett; 1998 Apr; 126(2):221-5. PubMed ID: 9585070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblasts.
    Hiwasa T; Ohkoshi M
    Anticancer Res; 1996; 16(4A):1823-6. PubMed ID: 8712707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
    Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
    Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
    Shinoda K; Shibuya M; Hibino S; Ono Y; Matsuda K; Takemura A; Zou D; Kokubo Y; Takechi A; Kudoh S
    Int J Oncol; 2003 Feb; 22(2):281-8. PubMed ID: 12527923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in growth factor receptors after treatment with serine protease inhibitor ONO-3403.
    Hiwasa T; Shimada H; Ochiai T; Liu TL; Yuasa Y; Takiguchi M; Ohkoshi M
    Int J Oncol; 2002 Apr; 20(4):797-802. PubMed ID: 11894127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428.
    Alonso DF; Tejera AM; Farias EF; Bal de Kier Joffe E; Gomez DE
    Anticancer Res; 1998; 18(6A):4499-504. PubMed ID: 9891516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway.
    Shih YW; Wu PF; Lee YC; Shi MD; Chiang TA
    J Agric Food Chem; 2009 May; 57(9):3490-9. PubMed ID: 19326946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer].
    Ohta T; Futagami F; Arakawa H; Tsukioka Y; Kitagawa H; Kayahara M; Nagakawa T; Miyazaki I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1669-72. PubMed ID: 8886041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of mouse autochthonous skin cancer by oral administration of new serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2002; 22(2A):821-3. PubMed ID: 12014657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells.
    Sakukawa R; Murakami K; Ikeda T; Yamada Y; Saiki I
    Oncol Res; 1998; 10(6):287-93. PubMed ID: 9848099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
    Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
    Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.